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Transcranial Doppler findings during thoracic
endovascular aortic repair
Jean Bismuth, MD, Zsolt Garami, MD, Javier E. Anaya-Ayala, MD, Joseph J. Naoum, MD,
Hosam F. El Sayed, MD, Eric K. Peden, MD, Alan B. Lumsden, MD, and
Mark G. Davies, MD, PhD, MBA, Houston, Tex
Objective: Thoracic endograft placement has become an acceptable treatment alternative to open repair of the thoracic
aorta. Cerebral embolization when manipulating the aortic arch during cardiac catheterization is well described, but the
influence of thoracic endovascular aortic repair (TEVAR) on this event remains poorly studied. Our aim was to quantify
the number of microembolic signals (MES) detected by transcranial Doppler (TCD) during different stages of TEVAR
and correlate them with landing zones, subclavian revascularization, and postoperative morbidity and mortality.
Methods: TCD was used to monitor 20 patients during TEVAR for the treatment of thoracic aortic aneurysms (TAAs) in
17 (85%) patients, followed by three (15%) with chronic type B aortic dissection and one (5%) Crawford type I
thoracoabdominal aortic aneurysm (TAAA). Imaging and medical parameters were entered into a combined database.
TCD signals were recorded digitally for the entire case. MES, velocities, and pulsatility index values were entered into a
combined database.
Results: The total number of MES calculated for the diagnostic phase before TEVAR placement and during the treatment
phase for all cases combined was 1081 and 1141, respectively. The highest MES counts were generated by the pigtail
catheter placement during the diagnostic phase and by device placement during the treatment phase. Embolic count to
right/left sides was equal overall. In the diagnostic phase, an average of nine MES were seen right/left, whereas during
the treatment phase, 45 and 43 MES were seen, respectively, for right/left. A significant association was found between
the total number of MES and postoperative stroke, transient ischemic attack (P  .0055), and death (P  .0053).
Conclusions: TCD can detect microemboli during TEVAR and is able to identify the procedural aspects most associated
with cerebral microemboli. ( J Vasc Surg 2011;54:364-9.)
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aThoracic endovascular aortic repair (TEVAR) of de-
scending thoracic aortic aneurysms (TAAs) was first de-
scribed by Volodos et al in 1991.1 Open surgical repair of
TAAs remains the historical standard but is associated with
higher rates of 30-day morbidity and mortality.2 Stroke is a
particularly debilitating morbidity that occurs about 9% of
the time during open procedures and at least 3% of the time
during TEVAR.3 These stroke rates are supported by pre-
vious pivotal trials for the Gore TAG (W. L. Gore and
Associates, Flagstaff, Ariz) Talent (Medtronic, Minneapo-
lis, Minn), and TX2 (Cook, Bloomington, Ind) grafts.4-7
Conventional computed tomography scans have been
relatively insensitive in detecting small-vessel ischemic le-
sions, particularly those that are apparently asymptom-
atic.8,9 Diffusion-weighted imaging for magnetic reso-
nance scans provides a valuable adjunct for detecting
clinically asymptomatic ischemic lesions. One study10 doc-
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364mented positive findings in 16% of patients; however, this
alls short of detecting all in situ microemboli during and
fter intervention.
Microemboli are considered the main cause of stroke
fter TEVAR procedures.11 Transcranial Doppler (TCD)
maging provides an important tool for the real-time detec-
ion of emboli during manipulation of the thoracic aorta
nd its cerebral branches. Manipulation of the aortic arch
uring cardiac catheterization has likewise been identified
s a source of cerebral embolization.12 The influence of
ndograft placement on cerebral embolization and flow is
ot well studied. The aim of this study was to quantify the
umber of microembolic signals (MES), velocities, and
ulsatility index detected by TCD during the diagnostic
nd deployment stages of the TEVAR and correlate these
ndings with landing zones, subclavian revascularization,
nd postoperative morbidity and mortality.
ATIENTS AND METHODS
Study design. Between February 2007 and July 2008,
0 patients underwent Gore TAG Excluder thoracic endo-
rosthesis placement while being monitored by TCD. All
atients provided informed consent, and the Institutional
eview Board at The Methodist Hospital approved this
rospective study. Imaging and medical parameters were
ntered into a combined database. The study took place in
n academic medical center with 1000 beds in a catchment
rea of 5 million people. It is a tertiary and quaternary
eferral facility.
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Volume 54, Number 2 Bismuth et al 365Study population. The study included patients with
descending TAAs of more than twice the diameter of the
adjacent aorta or a saccular aneurysm with a thrombus-free
nonaneurysmal proximal aortic landing zone 20 mm in
length and with angulation of the aortic segment of 60°.
The 20 patients (11 women, 9 men) were an average age of
65  22 years. Of these, 20% had hypertension, 30% had
coronary artery disease, 20% had arrhythmia, 25% had
peripheral arterial disease, 10% had diabetes, 10% had con-
gestive heart failure, 20% had chronic obstructive pulmo-
nary disease, and 25% had history of cerebral ischemia.
Another 10% had renal insufficiency, with a creatinine value
of1.4mg/dL, and 10% required hemodialysis at the time
of the surgery. A history of tobacco use was prevalent in
40%, and 10% were using tobacco at the time of the
procedure.
Five patients (25%) reported a history of aortic surgery,
including TAA repair, arch debranching with ascending
thoracic aorta replacement, and open aortobiiliac graft. At
presentation, 40% of patients were symptomatic. The most
common presenting symptom was chest pain (35%), fol-
lowed by back pain (25%) and respiratory complaints
(25%). Two patients (10%) were managed emergently.
Most patients (85%) were American Society of Anesthesi-
ology (ASA) class 4, 10% were class 3, and 5% were class 5.
Patients who required left common carotid artery–left sub-
clavian artery bypass to secure an adequate proximal land-
ing zone were included, and all received debranching be-
fore TEVAR, and so monitoring was the same for all
patients.
Methods. The procedures were performed in a hybrid
operative suite with the patient placed under general anes-
thesia. We quantified the number of MES, velocities, and
pulsatility index detected by TCD during different stages of
the endograft placement and correlated them with landing
zones, subclavian revascularization, and the number of
devices used. Systemic heparin (1000 U/kg) was given to
each patient before the treatment phase. TCD measure-
ments were taken at access wire placement, pigtail catheter
deployment, stiff wire exchange, contralateral wire place-
ment, device advancement, device deployment, delivery
system removal, device ballooning, and balloon removal.
Data were categorized into the diagnostic phase (DP),
encompassing access to contralateral wire placement, and
the treatment phase (TP), encompassing device deploy-
ment. In patients where we were able to monitor the
bilateral middle cerebral arteries (MCAs) simultaneously,
the number of MES was quantified on each side; and we
used these numbers to compare MES between the right
and left sides in each case.
TCD machine and software settings. Doppler pa-
rameters for our PMD100 (Spencer Technologies, Seattle,
Wash) were transducer, 2 MHz; 13-mm circular probe
surface; pulse repetition frequency, 8 kHz; fast Fourier
transformation, 128 points; overlap, 66%; sample volume
axial length, 9 mm; output power, 80%-100% (700 mW/
cm2 spatial peak temporal average intensity); filter, 125-
175 Hz; noise 0-3 dB; range, 30 dB; Doppler volume, 4 (B; M-mode range, 30 dB; and sweep period, 4-16 sec-
nds. We identified the proximal MCA bilaterally. The
-mode screen enables visualization of intracranial flow
ignals from depths of between 25 and 85 mm from the
ltrasound probe, making it easier for the sonographer to
ocalize the blood flow in the target vessel (Fig 1). The
CD signal was continuously recorded, and postproce-
ural analysis of the recording was completed for quantifi-
ation of MES.
Detection of MES. Criteria have been previously de-
cribed in our study of simultaneous prefilter and postfilter
CDmonitoring during carotid artery stenting,13 based on
uidelines of the Ninth International Cerebral Hemody-
amic Symposium Consensus Committee.14 The MES re-
orded on the power motion mode Doppler screen can be
racked as they move through the intracerebral circulation
Fig 2). An embolus traveling up the MCA would first
ppear in the proximal portion of the artery on power
otion mode Doppler at 60 mm and then travel distally in
he MCA at 40 mm. They would not be counted by the
utomatic embolus detection. Air emboli during contrast
njection were also excluded from our analysis, but we were
ble to visualize and differentiate contrast injection and
mbolism (Fig 2).
Statistical analysis. Measured values are reported as
ercentages or means  standard deviation. The Mann-
hitney U test was used for statistical analysis as appropri-
te, and association of nominal variables was tested by the
isher exact test.
ESULTS
Isolated degenerative TAAs were present in 17 patients
85%), followed by chronic type B aortic dissection in three
ig 1. A, Power M-mode Doppler (PMD) screen during trans-
ranial monitoring. B, Spectra. Channel 1 indicates vessel label:
ight middle cerebral artery (RMCA); channel 2, left MCA
LMCA; white box on the left side of the screen). Right side box:
elocity and emboli counting parameters. The microembolic sig-
als recorded on the PMD screen can be tracked as they move
hrough the intracerebral circulation.15%) and one Crawford type I thoracoabdominal aortic
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August 2011366 Bismuth et alaneurysm (TAAA; 5%). In 10% of patients, arch aneurysms
involved the ascending aorta or a descending TAAA in-
volved the visceral vessels. Among patients with TAA, 13
were isolated to descending, and four involved the arch.
Arch type 2 was present in six patients, followed by type 3 in
five, and type 1 in three.
A hybrid repair with open aortic debranching was re-
quired in 11 patients (55%), with five patients (35%) man-
aged through a staged approach. All debranching proce-
dures were limited to the aortic arch, requiring a
sternotomy in five patients, a supraclavicular approach in
three, and a right anterior minithoracotomy in three. Three
women required a conduit secondary to difficult iliac anat-
omy. Prophylactic spinal drainage was based on operator
preference and patient safety (length of covered aorta and
coagulopathy) and was used in 50% of patients. The mean
operative length was 204  132 minutes.
There was 100% technical success with TCD monitor-
ing during the diagnostic and treatment phases of en-
dograft placement. An average of two devices (range, 1-6
devices) were deployed per patient. The left subclavian
artery orifice was covered in 70% of the patients, and 79% of
these individuals underwent left common carotid artery–
left subclavian artery bypass. This corresponded to proxi-
mal fixation at landing zone 0 in five patients, zone 1 in one
patient, zone 2 in seven patients, zone 3 in five patients, and
zone 4 in two patients (Fig 3).
Intraoperative endoleak occurred in four patients
(20%) and was corrected immediately with ballooning or
deployment of an additional cuff. Seven (35%) patients
required an intraoperative blood transfusion. Intraopera-
tive hypotension occurred in 65% of the patients. One
instance of moderate hypotension (80 mm Hg) lasted 3
minutes, and one instance of severe hypotension (70 mm
Hg) persisted for 15 minutes.
There were no intraoperative deaths, and the 30-day
Fig 2. Transcranial Doppler screen: Bilateral middle cerebral ar-
tery (MCA) monitoring. Brightness changes at yellow arrow indi-
cate contrast media arrival into both MCAs at the same time.postoperative mortality was 5% (one patient). One late aeath occurred in a patient who died of cardiac arrest. All
emaining patients were alive at a mean follow-up of 24.2
onths. Four patients (20%) presented with a postopera-
ive cerebrovascular accident (CVA) or transient ischemic
ttack (TIA).
TCDfindings. Bilateral MCAmonitoring was used in
5 patients, left MCA monitoring was used in three, and
wo of those also had simultaneous left vertebral artery
onitoring. In two patients, only the right MCA was
onitored (Table I). Although TCD probe placement
oes not require significant time, bilateral monitoring is
ifficult to perform during emergencies or in situations
here there is a lack of space near the patient’s head.
The total number of MES calculated for the DP
efore TEVAR placement and during TP for all cases
ombined was 1081 and 1141, respectively. The highest
ES counts were generated by the pigtail catheter dur-
ng the DP and by device deployment during TP. Em-
olic counts to the right/left sides were the same overall.
n average of nine MES were seen right/left in DP,
hereas during TP, 45 and 43 MES were seen, respec-
ively, for right and left.
A significantly greater number of MES were counted
hen the device was deployed at landing zone 1 than in
anding zones 2 and 3 or 4. When analyzing the entire
P separately, devices deployed in landing zones 0 to 2
eleased more MES than those in landing zones 3 or 4.
urthermore, in the TP, landing zones 0 to 2 were
Fig 3. Number of patients per landing zone in this series.
able I. Monitoring of the vessels among the 20
atients included in this series
Monitoring Patients, No.
Bilateral MCA 15
Left MCAa 3
Right MCA 2
CA, Middle cerebral artery.
With simultaneous left vertebral artery monitoring.ssociated with more MES than landing zones 3 and 4
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Volume 54, Number 2 Bismuth et al 367(P .027; Fig 4). There was no difference in numbers of
MES related to arch type. Interestingly, we noted a
greater number of MES associated with zone 1 (54 9),
followed by zone 0 (20  4) and zone 2 (12  4),
particularly during the device deployment (Table II).
When treatment of thoracic aortic pathology required
coverage of the left subclavian artery orifice, no more MES
were noted than when the left subclavian artery was not
covered. Analysis within the subgroup for whom the left
subclavian artery was covered by the endograft revealed
that increased numbers of MES were observed specifically
during the device deployment phase over elements within
the DP (P  .001). This was not the case when the left
subclavian artery was not covered. Debranching the left
subclavian artery did not lead to any more MES outside of
the differences already observed to be associated with the
landing zone.
Although the Tri-Lobe Balloon (W. L. Gore and Asso-
ciates) offers continuous flow and decreases the “wind-
sock” effect,15 we observed significant variation in blood
flow velocity (P .0144) and pulsatility index (P .0001)
through the MCA and during balloon inflations, with
significant decrease (below baseline) at deflation (P  .05;
Fig 5). Significant association was found between the total
number of MES and postoperative stroke, TIA (P 
Fig 4. Microembolic signals (MES) during the diagnos
the entire treatment phase (TP) was analyzed separately,
than those in landing zones 3 or 4 (P  .027).
Table II. Number of microembolic signals associated
with landing zones 0 to 2 during device deployment
Landing zone MES, No. (mean  SD)
Zone 0 20  4
Zone 1 54  9
Zone 2 12  4
MES, Microembolic signals; SD, standard deviation..0055), and death (P  .0053). iISCUSSION
This study indicates that cerebral ischemia from intra-
perative emboli is a significant and often unrecognized
orbidity during aortic repair near the aortic arch. The use
f thoracic endoprosthesis to treat a variety of thoracic
ortic pathologies has rapidly increased, primarily to its
elative ease of application and decreased initial morbidity.
lthough TEVAR has succeeded in decreasing periopera-
ive morbidity and mortality, stroke rates remain relatively
nchanged.
Benefits of TCD. Emboli from the aortic arch and its
ranches can come in a variety of sizes, from grains visible
o the naked eye to debris 60 m, less than the pore size
ase (green bars) and treatment phase (blue bars). When
es deployed in landing zones 0 to 2 released more MES
ig 5. Transcranial Doppler screen: Bilateral middle cerebral ar-
ery (MCA) monitoring during balloon in/deflation. Nine sec-
nds of inflation/deflation shows waveform and velocity changes
n both sides (white arrow: inflation starts, yellow: deflation starts,
alloon was inflated for 6 seconds equals the time frame between
he two arrows).tic ph
devicn current filter devices.16 TCD allows real-time monitor-
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August 2011368 Bismuth et aling ofMES during TEVAR and reports ongoing changes in
flow velocities in the intracerebral circulation due to the
manipulation of the aortic arch and branches. TCD can also
provide a functional assessment of contralateral circula-
tions. We observedMES during various phases of diagnosis
and treatment. TCD also has the potential to support
research initiatives as we try to develop new products, as
well as test the embolic potential in current devices. Sauren
et al17 demonstrated the feasibility of the EmBlocker ultra-
sonic device (Neurosonix Ltd, Or-Yehuda, Israel) to deflect
microemboli from the cerebral vasculature using TCD-
based quantification of MES.17
Risk of CVA during aortic arch manipulation.
Feezor et al18 reported the relative occurrence of perioper-
ative stroke with TEVAR and noted that the incidence of
CVA was highest with TAAs (44.4%), followed by pene-
trating ulcers (33.3%) and then dissections (22.2%). They
also reported increased CVA occurrence if the distribution
of pathology involved the descending thoracic aorta, par-
ticularly zone 2 (35%) and zone 4 (33%).18
The prevalence of aneurysmal disease and paucity of
dissections and penetrating ulcers in our patient population
prevented adequate statistical analysis of MES associated
with aortic pathology. The number of MES associated with
coverage was higher during device deployment but was not
significantly greater than the MES observed when the left
subclavian was not covered. We did not find any association
of MES with debranching (carotid-subclavian bypass). Pe-
terson et al19 reviewed the literature on outcomes of
TEVAR when comparing coverage of the left subclavian
artery vs carotid-subclavian bypass and found eight times
more neurologic events associated with subclavian cover-
age vs bypass (24% vs 3%). This analysis was supported by
subsequent studies using the Cook TX2 endograft and the
Valiant graft, which both reported increased stroke with
placements of the graft in the descending thoracic aorta and
without revascularization of the subclavian artery.20,21 Al-
though our numbers are relatively small, our analysis indi-
cated that landing zones may be a potential predictor of
significant MES. Other reports have not demonstrated any
significant difference in stroke rate predicated on the land-
ing zone.22
Holzer et al23 attempted to assess the value of TCD in
predicting clinical outcome after TIA. They reported that
38.9% of patients with abnormal TCD findings went on to
have a new cerebral ischemic event. TCD used to monitor
cerebral integrity during single-stage TAAA repair implied
the feasibility of TCD-mediated monitoring of cerebral
blood flow.24
Our data indicate that there is significant variation in
the velocity of blood flow through the MCA before, dur-
ing, or after ballooning the stent graft and support asser-
tions that the Gore TAG and Trilobe Balloon Catheter
facilitate the maintenance of cerebral blood flow during
device deployment and ballooning. Our focus was on mon-
itoring embolization, but velocity changes during the en-
tire surgery could be studied in the future for hemodynamic
correlation with blood pressure management and anesthe- Aia efforts. These findings support the use of TCD to
onitor emboli and cerebral blood flow during procedures
nvolving the aortic arch.
Limitations of TCD. TCD is confined by the same
imitations associated with other ultrasound-based imaging
odalities. It is operator-dependent and sometimes limited
y suboptimal bone windows in up to 16% of cases.25 In the
resent series, we used one experienced operator for all the
ases. Power M mode TCD improved embolus detection
y 40% compared with previous single-channel methods.26
lso, the machine has only two channels; thus, if we were
nterested in monitoring one of the vertebral arteries, we
ad to forego the MCA monitoring. Another limitation is
hat this device is not able to differentiate between air and
olid particles.27
True significance of microemboli. It is essential to
stablish a correlation between the number of emboli and
icroinfarction and stroke. Several studies have specifically
ddressed this issue, indicating that a general count of 50
ES places a patient at significantly greater risk of clinical
troke.28,29 There are also reports indicating the cumula-
ive effect of microemboli may be an etiology of cognitive
hanges in memory and processing as we age. Therefore,
he prevention of emboli may pay dividends in the func-
ional status of our quickly aging population that are not
mmediately apparent, even on postoperative diffusion-
eighted imaging. However, as recent studies have sup-
orted, microemboli are not the only factor in cognitive
mpairment. Cerebral protection devices used to signifi-
antly reduce MES as monitored by TCD during cardio-
horacic surgery, particularly aortic andmitral valve replace-
ents, did not affect rates of cognitive dysfunction.30,31 It
emains to be seen what the long-term sequelae of subclin-
cal embolic events on cognitive function will be. Neverthe-
ess, it seems intuitive that we should do our best during
rocedures involving the aortic arch, specifically TEVARs,
o diminish the number of emboli that escape into the
erebral circulation. Not surprisingly, our findings support
ocusing on the device deployment phase of endograft
lacement.
ONCLUSIONS
The ability of TCD to detect cerebral emboli and
lterations in blood flow patterns is important to elucidate
hich steps of TEVAR or other procedures are most likely
o provoke hemodynamic changes and embolic events. It
lso has a potential to compare endografts and their differ-
nt capacities to generate emboli. We propose that further
se of TCDmonitoring during TEVAR provides meaning-
ul information about the risk of potential hazardous flow
attern changes and not just the embolization rates. Mon-
toring of the left vertebral artery specifically might provide
ore information about the need for left subclavian artery
overage.
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